BUZZ-Street View: Investors may question if further revisions to Molina's forecast are needed

Reuters
07/24
BUZZ-Street View: Investors may question if further revisions to Molina's forecast are needed

** Molina Healthcare MOH.N on Wednesday cut its annual profit forecast for the second time this month, anticipating higher medical care costs to weigh on its results.

** The company now expects adjusted full-year profit to be at least $19.00 per share, compared to its previous range of $21.50 to $22.50 per share

RESETTING THE BAR TO AN ACHIEVABLE LEVEL FOR 2025

** Baird ("Neutral", PT: $373) says the implied medical cost ratio in the second half "does not appear to be overly conservative which makes us a bit cautious, given all the potential additional shoes that could drop"

** Barclays ("Equal weight", PT: $270) adds most investors expected Molina to cut forecast again at some point this year

** J.P. Morgan ("Neutral", PT: $272) says the revised forecast is "resetting the bar to an achievable level for 2025", but the company will need to articulate improvement from higher medical costs against the backdrop of an uncertain 2026.

** Jefferies ("Hold", PT: $291) says the spike in Molina's Medicaid costs "adds another leg to an already strong anti-Medicaid bias"

(Reporting by Sriparna Roy in Bengaluru)

((Sriparna.Roy@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10